AVI BioPharma

AVI BioPharma are focused on the discovery and development of novel RNA-based therapeutics for rare and infectious diseases, as well as other select disease targets.

They have built a pipeline of potentially transformative therapeutic agents, including a clinical stage Duchenne muscular dystrophy candidate and anti-infective candidates for influenza and hemorrhagic fever viruses.

Address
3450 Monte Villa Parkway
Bothell
98021
United States of America

Website www.avibio.com